


| Key | % Net Assets |
|---|---|
| 3.1% | |
| 2.8% | |
| 2.5% | |
| 2.4% | |
| 89.2% |
| Name | % Net Assets |
|---|---|
| Sanofi | 3.1% |
| SAP | 2.8% |
| Novo Nordisk B | 2.5% |
| Anheuser-Busch InBev NV | 2.4% |
| UCB | 2.3% |
| Continental | 2.2% |
| Trygvesta A/S | 2.2% |
| Volvo AB | 2.2% |
| Dragon Oil | 2.1% |
| Banco Santander Central Hispano | 2.1% |
No asset data available.
| Date | 03-Mar-2023 |
|---|---|
| NAV | 262.10p |
| Currency | GBP |
| Change | 3.90p |
| % | 1.51% |
| YTD change | 262.10p |
| YTD % | n/a |
| Fund Inception | 16/11/1998 |
|---|---|
| Fund Manager | Jaime Ramos-Martin |
| TER | 1.68 (28-Sep-2012) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | 4.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.12 |
You are here: research